Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / SHS USD
-
Number of holders
-
350
-
Total 13F shares, excl. options
-
50,851,163
-
Shares change
-
-2,118,337
-
Total reported value, excl. options
-
$8,787,073,066
-
Value change
-
-$333,804,300
-
Put/Call ratio
-
185%
-
Number of buys
-
184
-
Number of sells
-
-171
-
Price
-
$172.79
Significant Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q1 2015
428 filings reported holding JAZZ - Jazz Pharmaceuticals plc - SHS USD as of Q1 2015.
Jazz Pharmaceuticals plc - SHS USD (JAZZ) has 350 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50,851,163 shares
.
Largest 10 shareholders include FMR LLC (8,936,249 shares), PUTNAM INVESTMENTS LLC (8,135,675 shares), VANGUARD GROUP INC (3,713,516 shares), WESTFIELD CAPITAL MANAGEMENT CO LP (2,332,377 shares), JANUS CAPITAL MANAGEMENT LLC (1,993,973 shares), STATE STREET CORP (1,235,529 shares), Bank of New York Mellon Corp (1,147,661 shares), FRANKLIN RESOURCES INC (975,795 shares), WELLINGTON MANAGEMENT GROUP LLP (957,674 shares), and WELLS FARGO & COMPANY/MN (927,977 shares).
This table shows the top 350 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.